These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30716080)

  • 1. Characteristics of measles epidemics in China (1951-2004) and implications for elimination: A case study of three key locations.
    Yang W; Li J; Shaman J
    PLoS Comput Biol; 2019 Feb; 15(2):e1006806. PubMed ID: 30716080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 60-year review on the changing epidemiology of measles in capital Beijing, China, 1951-2011.
    Li J; Lu L; Pang X; Sun M; Ma R; Liu D; Wu J
    BMC Public Health; 2013 Oct; 13():986. PubMed ID: 24143899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination.
    Funk S; Knapp JK; Lebo E; Reef SE; Dabbagh AJ; Kretsinger K; Jit M; Edmunds WJ; Strebel PM
    BMC Med; 2019 Sep; 17(1):180. PubMed ID: 31551070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic transition and the dynamics of measles in six provinces in China: A modeling study.
    Li S; Ma C; Hao L; Su Q; An Z; Ma F; Xie S; Xu A; Zhang Y; Ding Z; Li H; Cairns L; Wang H; Luo H; Wang N; Li L; Ferrari MJ
    PLoS Med; 2017 Apr; 14(4):e1002255. PubMed ID: 28376084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study.
    Hao L; Glasser JW; Su Q; Ma C; Feng Z; Yin Z; Goodson JL; Wen N; Fan C; Yang H; Rodewald LE; Feng Z; Wang H
    Int J Epidemiol; 2019 Aug; 48(4):1240-1251. PubMed ID: 30977801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern China.
    Yang Z; Xu J; Wang M; Di B; Tan H; He Q; Cai Y; Liang J; Hu W; Dong Z; Yang Y; Fu C
    Hum Vaccin Immunother; 2014; 10(4):1091-6. PubMed ID: 24513504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaching measles elimination in Switzerland: changing epidemiology 2007-2018.
    Richard JL; Mäusezahl M; Basler S; Eckert N
    Swiss Med Wkly; 2019 Jun; 149():w20102. PubMed ID: 31185128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of measles persistence in Beijing, China: A modelling study.
    Chen J; Zhang W; Wang Y; Yang W
    Epidemiol Infect; 2023 Aug; 151():e144. PubMed ID: 37605994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.
    Ma C; Li F; Zheng X; Zhang H; Duan M; Yang Y; Hao L; Su Q; Rodewald L; Guo B; Xiao S; Wang H; Li L; Li J; Luo H; Gao L
    BMC Infect Dis; 2015 Jan; 15():23. PubMed ID: 25608672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles elimination and immunisation: national surveillance trends in Japan, 2008-2015.
    Inaida S; Matsuno S; Kobune F
    Epidemiol Infect; 2017 Aug; 145(11):2374-2381. PubMed ID: 28641590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population profile of measles susceptibility in Tianjin, China.
    Boulton ML; Wang X; Zhang Y; Montgomery JP; Wagner AL; Carlson BF; Ding Y; Li X; Gillespie B; Su X
    Vaccine; 2016 Jun; 34(27):3037-3043. PubMed ID: 27151881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiological and clinical characteristics of measles in Wenzhou, China, 2000-2010.
    Xu ZW; Chen YP; Yang MJ; Li WC; Liu Q; Lin J
    Epidemiol Infect; 2014 Jan; 142(1):20-7. PubMed ID: 23507425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015.
    Tang L; Zhou Y; Pan Y; Zhu H
    Vaccine; 2017 May; 35(22):2925-2929. PubMed ID: 28433329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles outbreak investigation in Guji zone of Oromia Region, Ethiopia.
    Belda K; Tegegne AA; Mersha AM; Bayenessagne MG; Hussein I; Bezabeh B
    Pan Afr Med J; 2017; 27(Suppl 2):9. PubMed ID: 28983397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological characteristics of measles from 2000 to 2014: Results of a measles catch-up vaccination campaign in Xianyang, China.
    Zhang RQ; Li HB; Li FY; Han LX; Xiong YM
    J Infect Public Health; 2017; 10(5):624-629. PubMed ID: 28254459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic of measles following the nationwide mass immunization campaign.
    Gao J; Chen E; Wang Z; Shen J; He H; Ma H; Zeng G; Zhu BP
    BMC Infect Dis; 2013 Mar; 13():139. PubMed ID: 23506461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the impact of spatial clustering of susceptibility for measles elimination.
    Truelove SA; Graham M; Moss WJ; Metcalf CJE; Ferrari MJ; Lessler J
    Vaccine; 2019 Jan; 37(5):732-741. PubMed ID: 30579756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identify the susceptibility profile to measles in the general population: Serological survey of measles antibodies in Shaanxi province, China, in 2016.
    Pei L; Yang Y; Zhao X; Zhang S; Yuan L; Liu Y; Yu Y
    Vaccine; 2017 Dec; 35(52):7250-7255. PubMed ID: 29153585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.